Analysis of Neutrophil Response in Chronic Periodontitis
NCT ID: NCT01233765
Last Updated: 2017-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2011-09-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The proposed study will include patients undergoing periodontal (gum) treatment who will be matched to periodontally healthy controls. Blood, gingival crevicular (gum) fluid and clinical measures will be collected both pre- and post-therapy to measure differences in cell behaviour both before, and following routine therapy.
Blood samples will be used to isolate peripheral blood neutrophils prior to analysis of their responses to different bacterial stimuli including oxygen radical, cytokine and extracellular trap release. Gingival Crevicular Fluid samples will be used to measure different biochemical markers that result from the production of Neutrophil Extracellular Traps (NETs). Routine clinical measures will be taken both pre- and post-therapy as a measure of treatment response.
Patient volunteers undergoing treatment will be asked to donate a total of four small samples of tissue from the gums whilst they are already anaesthetised for routine treatment. These will be approximately the size of a needle head (2mm2mm) and used to examine NET formation within the tissues and related processes. This will provide novel in-vivo data regarding this recently discovered method of neutrophil defence in innate immunity.
This proposal represents a novel study aimed at improving our current understanding of why inflammatory periodontitis develops in some patients but not others, as well as providing pointers to causal/noncausal relationships between periodontitis and important systemic conditions such as diabetes and rheumatoid arthritis.
Ultimately, novel treatment approaches and primary prevention (for periodontitis) or secondary prevention (for systemic disease) strategies may emerge.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Periodontal Disease and Circulatory Microbial Components
NCT01154855
Role of IL-37 Genetic Variants in Modulating Innate Immune Response to Periodontal Pathogens
NCT03161301
IL-32 Levels in Patients With Chronic Periodontitis
NCT02632981
Interaction Between Immune Cells and Bacteria Associated With Periodontitis
NCT03225950
B Cell Functions in Periodontitis
NCT02833285
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control volunteers with periodontal health
Control volunteers with periodontal health
No interventions assigned to this group
Patient volunteers with chronic periodontitis
Patient volunteers with chronic periodontitis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a minimum of 20 teeth
* Have chronic periodontitis or otherwise healthy volunteers (controls)
* Be capable of giving informed consent themselves and are able and willing to participate in the study
Exclusion Criteria
* Mouthwash use
* Special dietary needs (e.g. coeliac)
* Patients with physical or mental disability
* Pregnant women or those breastfeeding
* Patients whose medical history may place them at risk of complications from periodontal therapy (e.g. warfarinised volunteers)
* Patients taking long term anti-microbial or anti-inflammatory drugs
* Patients unable or unwilling to provide informed consent
* Taking dietary supplements (e.g. multivitamins, antioxidants, fish oils)
* Shows unwillingness, inability or lack of motivation to carry out the study procedures, or cannot conform to the protocol
* A course of antibiotic or anti-inflammatory therapy currently or in the previous 3 months
* Current orthodontic treatment (e.g. wearing braces or orthodontic devices)
* Currently participating in another dental trial
* Diabetics
* Smokers or have smoked up to within 5 years
* Those patients who disclose previous or current recreational drug use
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Birmingham
OTHER
Birmingham Community Healthcare NHS
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor I Chapple
Professor (PI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Birmingham School of Dentistry
Birmingham, West Midlands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RG_10-077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.